Timed response to inhaled nitric oxide in pulmonary hypertension. - Wikidata - wikimedia - TriplyDB

Timed response to inhaled nitric oxide in pulmonary hypertension.

Timed response to inhaled nitric oxide in pulmonary hypertension.

http://www.wikidata.org/entity/Q33805925

about

A review of therapeutic agents for the management of pulmonary arterial hypertension.

P2860

Q38946618-7F7DF2C5-D6C1-47A1-B440-2B19DA9048B5

P2860

Timed response to inhaled nitric oxide in pulmonary hypertension.

http://www.wikidata.org/entity/Q33805925

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Timed response to inhaled nitric oxide in pulmonary hypertension.

@ast

Timed response to inhaled nitric oxide in pulmonary hypertension.

@en

type

label

Timed response to inhaled nitric oxide in pulmonary hypertension.

@ast

Timed response to inhaled nitric oxide in pulmonary hypertension.

@en

prefLabel

Timed response to inhaled nitric oxide in pulmonary hypertension.

@ast

Timed response to inhaled nitric oxide in pulmonary hypertension.

@en

P1433

Q33805925-CDE6C7C3-1243-4065-B78D-E0B342AF54C6

P1476

Q33805925-8DE82F0C-6184-4289-BFC7-0C221C685E4F

P2093

Q33805925-24AB7540-67D1-4A07-9ECB-62C98E20E73E

Q33805925-39455E5B-C4A0-46F2-B414-D173ADB816D1

Q33805925-5C8C88A7-1CFA-4129-8371-8EE79950DFDB

Q33805925-95EB1373-69E8-498D-B3C6-321B0D8F6E2D

Q33805925-9BAA72C2-D63A-47D7-9FEC-61B1A1810435

Q33805925-AC1F0AD8-0FED-4248-8925-34DD2482CD82

Q33805925-F810D48F-2582-470C-B72A-E2A97282B914

P2860

Q33805925-15623AB8-A501-48AA-94D4-008C36F14022

Q33805925-3AC9DAB5-EA6D-4EE1-81A5-48001C3B81ED

Q33805925-586F0D0A-DFF8-4AD7-96E6-B624BBF8767B

Q33805925-68EEDE57-39DA-4BEA-9EEC-AF9836B4BB93

Q33805925-88C49C81-F9C6-4151-971F-819FB4A6D06E

Q33805925-9D81EF0E-A1A9-4C3F-8FB4-7D2DFCB8A4F3

Q33805925-A73F2450-3A48-45D5-97FA-F2F46CB7AB04

Q33805925-AFC8810C-A4FF-444C-93BD-C0E3123DCCBC

Q33805925-C4908F11-1112-490E-AEA3-57DBB319BCE6

Q33805925-CB03F65E-EDD9-4E12-98BC-BB06F6AA93F0

P304

Q33805925-FA21DCB2-7045-40DB-B600-2FA2C1894D81

P31

Q33805925-62F08AB3-D15D-4EF2-9222-FF9AFF771052

P356

Q33805925-3BB4B099-6BCC-4D8D-B66C-C2ABBD36E63F

P433

Q33805925-3748D0D9-F034-4191-B01E-82BEC0F3927A

P478

Q33805925-698DA65F-64FF-477A-AD1B-8799C93141BB

P50

Q33805925-C6518D67-92F1-43B7-9757-D27488B81F44

Q33805925-D680478E-DEA9-4969-83B6-ECE95A4BECF7

P577

Q33805925-2D101697-E716-40FA-932F-A2E82E43080F

P5875

Q33805925-8442EE99-5C43-4AED-BEAA-8C4DD4E48BD4

P698

Q33805925-79D13577-54CD-4EE0-9687-59D9004E7D28

P932

Q33805925-49FC46D5-F212-4B60-A964-516F9432E4D6

P356

P1433

Pulmonary circulation

P1476

Timed response to inhaled nitric oxide in pulmonary hypertension.

@en

P2093

David Badesch

http://www.w3.org/2001/XMLSchema#string

Ivan P Casserly

http://www.w3.org/2001/XMLSchema#string

James M Hunt

http://www.w3.org/2001/XMLSchema#string

John C Messenger

http://www.w3.org/2001/XMLSchema#string

John Carroll

http://www.w3.org/2001/XMLSchema#string

Joseph Kay

http://www.w3.org/2001/XMLSchema#string

Todd M Bull

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods for assessing agreement between two methods of clinical measurement

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

Diagnosis and assessment of pulmonary arterial hypertension.

Diagnosis of pulmonary arterial hypertension.

Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension.

Prevalence of acute vasoresponsiveness in patients with pulmonary hypertension: treatment implications.

Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine.

P304

103-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/674880

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Michael G Risbano

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263779012

http://www.w3.org/2001/XMLSchema#string

P698

25006425

http://www.w3.org/2001/XMLSchema#string

P932

4070755

http://www.w3.org/2001/XMLSchema#string